Product Advantages
Application Pipeline
Resource Library
Technology FAQs
Available Products
Lab Benefits
Make A Request
Laboratory FAQs
Overview
Support FAQs
Corporate
Leadership
Board of Directors
News & Media
Contact Us
» Corporate
Letter from the CEO
Company Fact Sheet
Quality Policy and Objectives
Investors
» Leadership
Peter Lea, Ph.D.
Claude Ricks
Andrew Morris, M.Sc., MBA
Thomas E.T. O'Connor
Kate Smith
Sasi Mudumba, Ph.D.
Denis Bosc, Ph.D.
Darryl Burke
Geihan Rizkalla, M.Sc., CQM
» Board of Directors
» News & Media
Press Releases
» Contact Us
Career Openings
News & Media
Recent Press Releases
Mar 10 2009
Mount Sinai Services to Offer SQI Diagnostics’ QuantiSpot RA Multiplexed Test Panel to its Customers
Feb 20 2009
SQI Diagnostics Reports First Quarter 2009 Financial Results
Feb 11 2009
SQI Diagnostics Authorized to CE Mark its Automated SQiDworks™ Diagnostics Platform and QuantiSpot™ Rheumatoid Arthritis Assay
Jan 23 2009
SQI Diagnostics Reports Fourth Quarter and Year End Financial Results
Jan 21 2009
SQI Diagnostics Inc. Raises Additional CDN$1.66 Million Under Private Placement
Dec 23 2008
SQI Diagnostics Inc. Raises CDN$3 Million With Private Placement
Dec 19 2008
SQI Diagnostics Inc. Announces Private Placement of up to C$5,000,000
Nov 25 2008
SQI Diagnostics Receives Health Canada Licenses for its Automated SQiDworks Platform and QuantiSpot Rheumatoid Arthritis Microarray Consumable Test
Nov 05 2008
CANADA VENTURE: SQI Diagnostics' Autoimmune Ambitions
Oct 29 2008
SQI Diagnostics Submits FDA 510(k) and Health Canada Medical Device License Filings
Oct 07 2008
SQI Diagnostics Announces Appointment of Senior VP, Sales and Marketing
Sep 17 2008
SQI Diagnostics Announces Positive Results from Mt. Sinai / Cleveland Clinic External Multi-Site Validation Studies
Aug 29 2008
SQI Diagnostics Reports Results for the Fiscal Third Quarter Ended June 30, 2008
View all press releases »